Center for Translational Research acquires Zelmic AB

Center for Translational Research acquires Zelmic AB

Center for Translational Research AB (CTR) expands by acquiring Zelmic AB, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal pharmaceutical...
New chairman of the board and board member in CTR

New chairman of the board and board member in CTR

After 7 years as chairman of the board of Center for Translational Research (CTR), chairman and founder Bengt Dahlström handed over the chairmanship to Hans Andreasson at the General meeting on 23 May. Bengt started as chairman of the board of Clinical Trial...
Första poddavsnittet ute nu

Första poddavsnittet ute nu

Idag, den 12:e april, släpptes första avsnittet av podcasten Idé till patient. I pilotavsnittet ”En inledning till translationell forskning” diskuteras förväntningar och innehåll för kommande avsnitt. Karin Meyer, VD för CTR, kommer tillsammans med Frida...
CTR launches podcast together with SwedenBIO

CTR launches podcast together with SwedenBIO

The first episode of the podcast Idé till patient (Idea to patient) will be released on April 12. The podcast series is a co-production between the companies within the CTR-group and SwedenBIO. The series comprises six episodes where invited guests from the pharma...